127 related articles for article (PubMed ID: 10789839)
21. Comparative evaluation of efficacy and safety of calcipotriol versus tacalcitol ointment, both in combination with NBUVB phototherapy in the treatment of stable plaque psoriasis.
Dua I; Aggarwal K; Jain VK
Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):275-281. PubMed ID: 28602032
[TBL] [Abstract][Full Text] [Related]
22. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
[TBL] [Abstract][Full Text] [Related]
23. High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids.
Katayama I; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(6):553-7. PubMed ID: 12459526
[TBL] [Abstract][Full Text] [Related]
24. High-concentration (20 μg g⁻¹ ) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trial.
Choi JW; Choi JW; Kwon IH; Youn JI
Br J Dermatol; 2010 Jun; 162(6):1359-64. PubMed ID: 20302582
[TBL] [Abstract][Full Text] [Related]
25. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice.
Lambert J; Trompke C
Dermatology; 2002; 204(4):321-4. PubMed ID: 12077538
[TBL] [Abstract][Full Text] [Related]
26. Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study.
Helfrich YR; Kang S; Hamilton TA; Voorhees JJ
Br J Dermatol; 2007 Aug; 157(2):369-74. PubMed ID: 17596167
[TBL] [Abstract][Full Text] [Related]
27. An update on vitamin D3 analogues in the treatment of psoriasis.
van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 1998; 11(1):2-10. PubMed ID: 9603664
[TBL] [Abstract][Full Text] [Related]
28. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
Calzavara-Pinton P; Rossi MT; Sala R; Venturini M
G Ital Dermatol Venereol; 2011 Aug; 146(4):295-9. PubMed ID: 21785396
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
Peeters P; Ortonne JP; Sitbon R; Guignard E
Dermatology; 2005; 211(2):139-45. PubMed ID: 16088161
[TBL] [Abstract][Full Text] [Related]
30. Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis.
Satake K; Amano T; Okamoto T
Eur J Pharmacol; 2018 May; 826():31-38. PubMed ID: 29476878
[TBL] [Abstract][Full Text] [Related]
31. Topical tacalcitol treatment for psoriasis.
Harrison PV
Hosp Med; 2000 Jun; 61(6):402-5. PubMed ID: 10962655
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients.
Prignano F; Buggiani G; Lotti T
Acta Biomed; 2009 Apr; 80(1):51-6. PubMed ID: 19705621
[TBL] [Abstract][Full Text] [Related]
33. Patch test study with calcipotriol ointment in different patient groups, including psoriatic patients with and without adverse dermatitis.
Fullerton A; Avnstorp C; Agner T; Dahl JC; Olsen LO; Serup J
Acta Derm Venereol; 1996 May; 76(3):194-202. PubMed ID: 8800298
[TBL] [Abstract][Full Text] [Related]
34. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
Tzaneva S; Hönigsmann H; Tanew A; Seeber A
Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423
[TBL] [Abstract][Full Text] [Related]
35. Tacalcitol ointment for psoriasis.
Nishimura M; Makino Y; Matugi H
Acta Derm Venereol Suppl (Stockh); 1994; 186():166-8. PubMed ID: 8073825
[TBL] [Abstract][Full Text] [Related]
36. Tacalcitol ointment for the treatment of nail psoriasis.
Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
[TBL] [Abstract][Full Text] [Related]
37. Tolerability of Crisaborole Ointment for Application on Sensitive Skin Areas: A Randomized, Double-Blind, Vehicle-Controlled Study in Healthy Volunteers.
Zane LT; Hughes MH; Shakib S
Am J Clin Dermatol; 2016 Oct; 17(5):519-526. PubMed ID: 27335049
[TBL] [Abstract][Full Text] [Related]
38. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the clinical effect of topical tacalcitol on ichthyoses with retentive hyperkeratosis.
Okano M
Dermatology; 2001; 202(2):116-8. PubMed ID: 11306831
[TBL] [Abstract][Full Text] [Related]
40. Proliferation is the main epidermal target in the treatment of psoriatic plaques with once daily application of tacalcitol ointment.
Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PJ; van de Kerkhof PC
Acta Derm Venereol; 1999 Mar; 79(2):111-4. PubMed ID: 10228627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
